Lucas Dean
Overview
Explore the profile of Lucas Dean including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
20
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang G, Albers P, Mookerji N, Pfanner T, Hui A, Mittal R, et al.
Eur J Nucl Med Mol Imaging
. 2024 Dec;
PMID: 39725694
Purpose: Fluorine-18 prostate-specific membrane antigen-1007 positron emission tomography/computed tomography (F-PSMA-1007 PET/CT) has been shown to be superior to multiparametric magnetic resonance imaging (MRI) for the locoregional staging of intermediate-risk and...
2.
Soytas M, Dragomir A, Sawaya G, Hesswani C, Tanguay M, Finelli A, et al.
BJU Int
. 2024 Dec;
PMID: 39631366
Objective: To evaluate and compare the outcomes of patients with localised renal cell carcinoma (RCC) with and without sarcomatoid features and the impact of this on cancer recurrence and survival....
3.
Mookerji N, Pfanner T, Hui A, Huang G, Albers P, Mittal R, et al.
JAMA Oncol
. 2024 Jul;
10(8):1097-1103.
PMID: 38949926
Importance: Prostate-specific membrane antigen (PSMA) demonstrates overexpression in prostate cancer and correlates with tumor aggressiveness. PSMA positron emission tomography (PET) is superior to conventional imaging for the metastatic staging of...
4.
Bernard S, Evans H, Hoy N, Suderman K, Cameron B, Sexsmith J, et al.
Contemp Clin Trials
. 2024 Mar;
139:107482.
PMID: 38431130
Background: Urinary incontinence (UI), erectile dysfunction and cardiometabolic conditions are common after prostatectomy for prostate cancer (PCa). Although physical activity could improve overall survival and quality of survivorship, fear of...
5.
Lemire F, Zhang M, Anderson P, Finelli A, Rendon R, Tanguay S, et al.
Can Urol Assoc J
. 2023 Nov;
18(2):55-60.
PMID: 37931286
Introduction: Robotic surgery is used in the treatment of kidney tumors. We aimed to determine if robotic access was associated with initial choice of management for patients with a clinical...
6.
Millan B, Breau R, Mallick R, Wood L, Rendon R, Finelli A, et al.
Urol Oncol
. 2023 May;
41(7):328.e15-328.e23.
PMID: 37202328
Purpose: To compare characteristics and outcomes of patients included versus those not in adjuvant therapy trials post complete resection of renal cell carcinoma (RCC). Methods: Adult patients following complete resection...
7.
Millan B, Breau R, Bhindi B, Mallick R, Tanguay S, Finelli A, et al.
J Urol
. 2022 Jun;
208(4):804-812.
PMID: 35686812
Purpose: Percutaneous ablation therapy (AT) and partial nephrectomy (PN) are successful management strategies for T1a renal cancer. Our objective was to compare AT to PN with respect to recurrence-free survival...
8.
Almassi N, Cha E, Vertosick E, Huang C, Wong N, Dason S, et al.
J Urol
. 2020 Jul;
204(4):684.
PMID: 32701382
No abstract available.
9.
Almassi N, Cha E, Vertosick E, Huang C, Wong N, Dason S, et al.
J Urol
. 2020 Apr;
204(4):677-684.
PMID: 32294398
Purpose: We evaluated trends in oncologic characteristics and outcomes as well as perioperative management among patients undergoing radical cystectomy at Memorial Sloan Kettering from 1995 to 2015. Materials And Methods:...
10.
Basourakos S, Dean L, Van Gurp J, Reuter V, Russo P
Can J Urol
. 2019 Oct;
26(5):9952-9955.
PMID: 31629446
Adrenal-renal fusion is an anomaly misclassified as a renal tumor due to the absence of pathognomonic radiographic features. Herein, we report a case of a 61-year-old male who underwent a...